| This week's sponsor is Premier Research. | |  | Immunotherapy: Unleashing the Body's Potential to Fight Cancer
The immune system's role in fighting cancer becomes clearer every day, and the therapeutic implications are enormous. Discover promising new approaches to immunotherapy in our new white paper.
Premier Research. It's what we do. Best. |
Featured Story | | | Monday, June 26, 2017 Roche has released a closer look at the data it hopes will propel hemophilia A drug emicizumab to blockbuster status. Emicizumab cut the bleed rate by 87% in patients with inhibitors to factor VIII and aced all the secondary endpoints, leaving lingering concerns about side effects as the main barrier between Roche and big sales. |
|
|
| This week's sponsor is Sensors Expo & Conference 2017. | |  | |
Top Stories Monday, June 26, 2017 Kala Pharmaceuticals has filed to list on Nasdaq. The ophthalmic drug R&D shop has penciled in a fundraising goal of $86 million to equip itself to file for approvals of corticosteroid nanosuspension KPI-121 in two indications. Monday, June 26, 2017 Small cap biotech Matinas BioPharma was off by nearly 50% premarket on data coming out of its midstage vulvovaginal candidiasis candidate. Monday, June 26, 2017 Neoantigen-based cancer vaccines represent new, truly personalized therapeutic approaches to treating cancer. Monday, June 26, 2017 It was a short and bitter update out of San Diego’s Neothetics today after it said a phase 2 proof-of-concept study for its fat reduction therapy flopped. Monday, June 26, 2017 RNA interference specialist Alnylam has hit the accelerator on its candidate drug for ultrarare porphyria diseases, prepping for phase 3 trials later this year after unveiling initial results in 12 patients. Monday, June 26, 2017 Philips is introducing its IntelliVue X3 patient monitoring system in Europe. The device is designed to monitor vitals at the bedside and when patients are being moved between locations to cut the risk of data loss. | This week's sponsor is J.P. Morgan Private Bank. | |  | How Your Assets Are Structured Can Have Long-Term Implications On Your Wealth
As a founder or executive of a healthcare business, it's crucial your assets are titled properly. J.P. Morgan Private Bank knows how to protect your assets and preserve your wealth. Download this article on asset ownership to learn more. |
| | | Verastem has posted new data from long-term follow-up of its phase 2 test of duvelisib on subsets of patients with follicular lymphoma or small lymphocytic lymphoma. Release Former Vice President Joe Biden and Jill Biden launched the Biden Cancer Initiative, their new venture aimed at treating and preventing cancer in new and innovative ways. Statement Synlogic says it has been handed a fast-track tag from the FDA for its lead product candidate, SYNB1020, for the rare disorder hyperammonemia. Release | |
|
Resources Sponsored By: HealthCore Gain critical insights into how to design and implement pragmatic trials and generate relevant, high-level real-world evidence. Learn when to conduct PTs, design considerations, ethical regulatory issues — and more. Sponsored By: Envigo Discover the factors that contribute to differential radiation sensitivity between the Rag2 and SCID models. Presented by: Veeva Hear three innovative leaders explain how regulatory can “go digital” in their operations by leveraging the data-handling capabilities in their RIM systems. Sponsored by Envigo Performing a sophisticated surgery to create a myocardial infarction model. Join us on June 7th at 11:00 AM EDT. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Sponsored By: Veeva Join this global webinar to learn a new approach for demonstrating medical affairs' impact with better metrics - beyond reach and frequency, enabling launch success and better engagement with strategic KOL insights, and increasing your organization's share of voice in the healthcare landscape. Sponsored By: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Sponsored By: DocuSign The patients who rely on your scientific leadership are expecting more. Sponsored By: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. | 
